Sialoglycoprotein and carbohydrate complexes in chromium toxicity

Current Opinion in Chemical Biology

Volumn 7, Issue 2, 2003, Pages 213-219

  Codd, Rachel ^a   Irwin, Jennifer A ^a,b   Lay, Peter A ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b CSIRO   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATE DERIVATIVE; CHROMIUM DERIVATIVE; SIALOGLYCOPROTEIN;

CARCINOGENESIS; ELECTRON SPIN RESONANCE; GENOTOXICITY; METABOLISM; REVIEW;

EID: 0037398781     PISSN: 13675931     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1367-5931(03)00017-6     Document Type: Review

References (46)

1. International Agency for Research on Cancer: Chromium, nickel and welding. In IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. International Agency for Research on Cancer: Lyon, France;1990.
2. Pellerin C., Booker S.M. Reflections on hexavalent chromium. Environ. Health Persp. 108:2000;A402-A407.
3. Steinpress M.G., Ward A.C. The scientific process and Hollywood: the case of hexavalent chromium. Ground Water. 39:2001;321-322 This publication summarizes the social implications and scientific case behind the large law suits in the USA on environmental chromium pollution.
4. Codd R., Dillon C.T., Levina A., Lay P.A. Studies on the genotoxicity of chromium: from the test tube to the cell. Coord. Chem. Rev. 216-217:2001;533-577 This is a review of the bioinorganic chemistry of Cr(VI) in relation to Cr-induced cancers. It contains a detailed section on Cr(V)-carbohydrate complexes.
5. Levina A., Codd R., Dillon C.T., Lay P.A. Chromium in biology: toxicology and nutritional aspects. Prog. Inorg. Chem. 51:2003;145-250 This is the most up-to-date and comprehensive review on the toxicology and nutritional effects of Cr and the underlying chemistry and biochemistry. It highlights areas that are still controversial.
6. V-saccharide complexes. J. Argent. Chem. Soc. 90:2002;1-19 This review provides a comprehensive summary on research on the characterization of Cr(V) saccharide complexes by EPR spectroscopy.
7. Sugiyama M. Role of paramagnetic chromium in chromium(VI)-induced damage in cultured mammalian cells. Environ. Health Perspect. 102:1994;31-33.
8. Liu K.J., Shi X., Jiang J., Goda F., Dalal N., Swartz H.M. Low frequency electron paramagnetic resonance investigation on metabolism of chromium(VI) by whole live mice. Ann. Clin. Lab. Sci. 26:1996;176-184 This research established that long-lived Cr(V) species were generated in mice exposed to carcinogenic chromium(VI).
9. Liu K.J., Mader K., Shi X., Swartz H.M. Reduction of carcinogenic chromium(VI) on the skin of living rats. Magn. Reson. Med. 38:1997;524-526.
10. Codd R., Lay P.A. Chromium(V)-sialic (neuraminic) acid species are formed from mixtures of chromium(VI) and saliva. J. Am. Chem. Soc. 123:2001;11799-11800 Carcinogenic Cr(VI) was reacted with saliva to produce long-lived Cr(V) complexes of sialoglycoproteins in which Cr(V) was bound to glycerol diolato groups of the terminal sialic acid residue. This is the first time that it was established that the extracellular reduction of Cr(VI) may also play a role in the observed Cr(VI) carcinogenicity.
11. Shi X., Dalal N.S., Vallyathan V. One-electron reduction of carcinogen chromate by microsomes, mitochondria and Escherichia coli: identification of chromium(V) and hydroxyl radical. Arch. Biochem. Biophys. 290:1991;381-386.
12. Wetterhahn Jennette K. Microsomal reduction of the carcinogen chromate produces chromium(V). J. Am. Chem. Soc. 104:1982;874-875.
13. Rossi S.C., Gorman N., Wetterhahn K.E. Mitochondrial reduction of the carcinogen chromate: formation of chromium(V). Chem. Res. Toxicol. 1:1988;101-107.
14. Martin B.D., Schoenhard J.A., Sugden K.D. Hypervalent chromium mimics reactive oxygen species as measured by the oxidant-sensitive dyes 2′,7′-dichlorofluorescin and dihydrorhodamine. Chem. Res. Toxicol. 11:1998;1402-1410.
15. Barr-David G., Charara M., Codd R., Farrell R.P., Irwin J.A., Lay P.A., Bramley R., Brumby S., Ji J.-Y., Hanson G.R. EPR characterisation of the Cr(V) intermediates in the Cr(VI)/Cr(V) oxidations of organic substrates and of relevance to Cr-induced cancers. J. Chem. Soc. Faraday Trans. 91:1995;1207-1216.
16. V. A comparative and mechanistic study. Carbohydr. Res. 316:1999;14-25.
17. Signorella S, Frascaroli MI, García S, Santoro M, González JC, Palopoli C, Daier V, Casado N, Sala LF: Kinetics and mechanism of the chromium(VI) oxidation of methyl α-D-glucopyranoside and methyl α-D-mannopyranoside. J Chem Soc Dalton Trans 2000:1617-1623.
18. Roldán V.P., Daier V., Goodman B., Santoro M.I., González J.C., Calisto N., Signorella S., Sala L.F. Kinetics and mechanism of the reduction of chromium(VI) and chromium(V) by D-glucitol and D-mannitol. Helv. Chim. Acta. 83:2000;3211-3228.
19. Rizzotto M., Moreno V., Signorella S., Daier V., Sala L.F. Electron paramagnetic resonance and potentiometric studies of the interactions of Cr(VI) and Cr(V) with D-ribose 5-phosphate and nucleotides. Polyhedron. 19:2000;417-423.
20. Krumpolc M., DeBoer B.G., Rocek J. A stable chromium(V) compound. Synthesis, properties, and crystal structure of potassium bis(2-hydroxy-2-methylbutyrato)oxochromate(V) monohydrate. J. Am. Chem. Soc. 100:1978;145-153.
21. Bramley R., Ji J.-Y., Judd R.J., Lay P.A. Solvent dependence of the EPR spectra of oxochromate(V) complexes: solution structures and the effects of hydrogen bonding between the solvent and the complex. Inorg. Chem. 29:1990;3089-3094.
22. Irwin JA: Cr(V)-sugar complexes: possible intracellular intermediates of importance to chromate-induced carcinogenesis [PhD Thesis]. University of Sydney: 1998.
23. Codd R., Lay P.A. Competition between 1,2-diol and 2-hydroxy acid coordination in Cr(V)-quinic acid complexes: implications for stabilization of Cr(V) intermediates of relevance to Cr(VI)-induced carcinogenesis. J. Am. Chem. Soc. 121:1999;7864-7876.
24. -. Eur J Inorg Chem 2001:1829-1833.
25. Codd R, Lay PA: Manuscript 2002.
26. Branca M., Dessi A., Kozlowski H., Micera G., Swiatek J. Reduction of chromate ions by glutathione tripeptide in the presence of sugar ligands. J. Inorg. Biochem. 39:1990;217-226.
27. Castells M.T., Ballesta J., Pastor L.M., Madrid J.F., Marin J.A. Histochemical characterisation of glycoconjugates in the epithelium of the extrapulmonary airways of several vertebrates. Histochem. J. 22:1990;24-35.
28. Blasiak J., Trzeciak A., Malecka-Panas E., Drzewoski J., Iwanienko T., Szumeil I., Wojewódzka M. DNA damage and repair in human lymphocytes and gastric mucosa cells exposed to chromium and curcumin. Teratogen. Carcin. Mut. 19:1999;19-31.
29. Shrivastava H.Y., Nair B.U. Cleavage of human orosomucoid by a chromium(V) species: relevance in biotoxicity of chromium. Biochem. Biophys. Res. Commun. 279:2000;980-983.
30. Fahr C., Schauer R. Detection of sialic acids and gangliosides with special reference to 9-O-acetylated species in basaliomas and normal human skin. J. Invest. Dermatol. 116:2001;254-260.
31. Judd RJ, Hambley TW, Lay PA: Electrochemistry of the quasireversible bis[2-ethyl-2-hydroxybutanoato(2-)]oxochromate(V) and -(IV) and bis[2-hydroxy-2-methylbutanoato(2-)]oxochromate(V) and -(IV) redox couples and the crystal and molecular structure of sodium bis[2-ethyl-2-hydroxybutanoato(2-)]-oxochromate(V) sesquihydrate. J Chem Soc Dalton Trans 1989:2205-2210.
32. Dillon C.T., Lay P.A., Bonin A.M., Dixon N.E., Sulfab Y. DNA interactions and bacterial mutagenicity of some chromium(III) imine complexes and their chromium(V) analogues. Evidence for chromium(V) intermediates in the genotoxicity of chromium(III). Aust. J. Chem. 53:2000;411-424.
33. Farrell R.P., Judd R.J., Lay P.A., Dixon N.E., Baker R.S.U., Bonin A.M. Chromium(V)-induced cleavage of DNA: are chromium(V) complexes the active carcinogens in chromium(VI)-induced cancers? Chem. Res. Toxicol. 2:1989;227-229.
34. Dillon C.T., Lay P.A., Bonin A.M., Dixon N.E., Collins T.J., Kostka K.L. In vitro DNA damage and mutations induced by a macrocyclic tetraamide chromium(V) complex: implications for the role of chromium(V) peptide complexes in chromium-induced cancers. Carcinogenesis. 14:1993;1875-1880.
35. Levina A., Barr-David R., Codd R., Lay P.A., Dixon N.E., Hammershøi A., Hendry P. In vitro plasmid DNA cleavage by chromium(V) and -(IV) 2-hydroxycarboxylato complexes. Chem. Res. Toxicol. 12:1999;371-381.
36. Sugden K.D., Wetterhahn K.E. Direct and hydrogen peroxide-induced chromium(V) oxidation of deoxyribose in single-stranded and double-stranded calf thymus DNA. Chem. Res. Toxicol. 10:1997;1397-1406.
37. Sugden K.D., Wetterhahn K.E. Identification of the oxidized products formed upon reaction of chromium(V) with thymidine nucleotides. J. Am. Chem. Soc. 118:1996;10811-10818.
38. Sugden K.D. Formation of modified cleavage termini from the reaction of chromium(V) with DNA. J. Inorg. Biochem. 77:1999;177-183.
39. Bose RN, Fonkeng BS: Mechanism of DNA damage by chromium carcinogens. Chem Commun 1996:2211-2212.
40. Bose R.N., Fonkeng B.S., Moghaddas S., Stroup D. Mechanisms of DNA damage by chromium(V) carcinogens. Nucleic Acids Res. 26:1998;1588-1596.
41. Bose R.N., Moghaddas S., Mazzer P.A., Dudones L.P., Joudah L., Stroup D. Oxidative damage of DNA by chromium(V) complexes: relative importance of base versus sugar oxidation. Nucleic Acids Res. 27:1999;2219-2226.
42. Levina A., Lay P.A., Dixon N.E. Disproportionation and nuclease activity of bis[2-ethyl-2-hydroxybutanoato(2-)]oxochromate(V) in neutral aqueous solutions. Inorg. Chem. 39:2000;385-395.
43. Levina A., Lay P.A., Dixon N.E. Disproportionation of a model chromium(V) complex causes extensive chromium(III)-DNA binding in vitro. Chem. Res. Toxicol. 14:2001;946-950.
44. Shi L: The in vitro effects of sugars in Cr(V)-induced cancers [MSc thesis]. University of Sydney: 2002.
45. Micera G., Dessi A. Chromium adsorption by plant roots and formation of long-lived chromium(V) species: an ecological hazard? J. Inorg. Biochem. 34:1988;157-166.
46. Appenroth K.J., Bischoff M., Gabrys H., Stoeckel J., Swartz H.M., Walczak T., Winnefeld K. Kinetics of chromium(V) formation and reduction in fronds of the duckweed Spirodela polyrhiza - a low frequency EPR study. J. Inorg. Biochem. 78:2000;235-242.